The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals.
Finnish Diagnostic Firm Actim Gets CE Mark for SARS-CoV-2 Antibody Test
Actim said the assay has 96 percent sensitivity and 98 percent specificity and it does not cross-react with IgG antibodies against other common viruses.
Oxford Immunotec, Valneva Collaborate on COVID-19 Vaccine Study
Oxford Immunotec's T-Spot Discovery SARC-CoV-2 test will be used to assess whether Valneva's vaccine candidate induces a T-cell response.
HHS Provides $22B to Expand COVID-19 Testing, Vaccinations
More than $19 billion will be given through the CDC Epidemiology and Laboratory Capacity cooperative agreement to support testing, contact tracing, and surveillance.
Roche SARS-CoV-2 Antibody Test to be Used in Moderna Vaccine Trials
Moderna's vaccine triggers antibody response specifically to the anti-receptor binding domain antibodies of the SARS-CoV-2 spike protein.